Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(3):162; doi:10.1093/jnci/djj062
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vastag, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vastag, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

NIH Institutes Launch Joint Venture To Map Cancer Genome

Brian Vastag

In December, National Institutes of Health leaders announced plans for a pilot program that they hope will map every genetic mutation involved in cancer. Francis Collins, M.D., Ph.D., director of the National Human Genome Research Institute, said that the effort, called the Cancer Genome Atlas, is a natural extension of the Human Genome Project.


Figure 1
View larger version (135K):
[in this window]
[in a new window]
 
Francis Collins

 
"When the first calls for the Human Genome Project came in 1986, it was characterized as the best way to vanquish cancer," he said at a press conference for the project's announcement.

The $100 million pilot project, to be funded equally by NHGRI and the National Cancer Institute, will begin early next year with the selection of five core centers, each focused on specific tasks. (See News, Vol. 97, No. 18, p. 1322, "Human Cancer Genome Project Moving Forward Despite Some Doubts in Community.")

NIH Director Elias Zerhouni, M.D., said that for the first time, "we will discover and make public all of the genetic mutations that eventually lead to cancer. We have caught glimpses of how those changes lead to cancer, but it is not enough."

To date, researchers have identified five to 15 genetic changes for each type of cancer, said NCI Deputy Director Anna Barker, Ph.D. But, she said, there are probably 100 or more such changes involved in the formation, growth, and metastasis of any particular type of cancer. "Each [genetic mutation] required years of effort" to identify and characterize, she said, but technologies developed during the human genome project will now speed up the process. "It will free scientists from identifying the mutations one by one."

The pilot project will focus on two or three types of cancers, which have not been selected. The 3-year project will shake out the system. If deemed successful, the program will scale up to tackle 50 or more types of cancer.

The five centers will include a biospecimen center to collect and process tumors, three cancer genome sequencing centers that will serve as the workhorses, and a bioinformatics center to store and analyze the reams of data generated. All of the data will be available for free online.

Originally, NCI estimated that the entire Cancer Genome Atlas would cost $1.5 billion over 10 years. But at the press conference, Collins said, "Quite frankly, we have no idea how much the whole thing would cost. It's impossible to predict. But the pilot project should lead to a sharply downward curve in costs." He referred again to the Human Genome Project, saying that at the beginning of that endeavor, each base pair sequenced cost about $10, whereas today each costs a tenth of a penny.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Dahl, J. Stenberg, S. Fredriksson, K. Welch, M. Zhang, M. Nilsson, D. Bicknell, W. F. Bodmer, R. W. Davis, and H. Ji
Multigene amplification and massively parallel sequencing for cancer mutation discovery
PNAS, May 29, 2007; 104(22): 9387 - 9392.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vastag, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vastag, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?